ID   PHLP1_RAT               Reviewed;        1696 AA.
AC   Q9WTR8;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=PH domain leucine-rich repeat protein phosphatase 1;
DE            EC=3.1.3.16;
DE   AltName: Full=Pleckstrin homology domain-containing family E member 1;
DE            Short=PH domain-containing family E member 1;
DE   AltName: Full=Suprachiasmatic nucleus circadian oscillatory protein;
GN   Name=Phlpp1; Synonyms=Phlpp, Plekhe1, Scop;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=10570941; DOI=10.1016/s0014-5793(99)01190-4;
RA   Shimizu K., Okada M., Takano A., Nagai K.;
RT   "SCOP, a novel gene product expressed in a circadian manner in rat
RT   suprachiasmatic nucleus.";
RL   FEBS Lett. 458:363-369(1999).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH KRAS.
RX   PubMed=12594205; DOI=10.1074/jbc.m213214200;
RA   Shimizu K., Okada M., Nagai K., Fukada Y.;
RT   "Suprachiasmatic nucleus circadian oscillatory protein, a novel binding
RT   partner of K-Ras in the membrane rafts, negatively regulates MAPK
RT   pathway.";
RL   J. Biol. Chem. 278:14920-14925(2003).
RN   [3]
RP   FUNCTION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY (ISOFORMS 1 AND 2), AND
RP   INDUCTION BY INSULIN.
RX   PubMed=20089132; DOI=10.1111/j.1471-4159.2010.06609.x;
RA   Kanan Y., Matsumoto H., Song H., Sokolov M., Anderson R.E., Rajala R.V.;
RT   "Serine/threonine kinase akt activation regulates the activity of retinal
RT   serine/threonine phosphatases, PHLPP and PHLPPL.";
RL   J. Neurochem. 113:477-488(2010).
RN   [4]
RP   ALTERNATIVE SPLICING, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=20819118; DOI=10.1111/j.1471-4159.2010.06984.x;
RA   Jackson T.C., Verrier J.D., Semple-Rowland S., Kumar A., Foster T.C.;
RT   "PHLPP1 splice variants differentially regulate AKT and PKCalpha signaling
RT   in hippocampal neurons: characterization of PHLPP proteins in the adult
RT   hippocampus.";
RL   J. Neurochem. 115:941-955(2010).
CC   -!- FUNCTION: Protein phosphatase involved in regulation of Akt and PKC
CC       signaling. Mediates dephosphorylation in the C-terminal domain
CC       hydrophobic motif of members of the AGC Ser/Thr protein kinase family;
CC       specifically acts on 'Ser-473' of AKT2 and AKT3, 'Ser-660' of PRKCB and
CC       'Ser-657' of PRKCA (PubMed:20819118). Isoform 2 seems to have a major
CC       role in regulating Akt signaling in hippocampal neurons while isoform 1
CC       may promote Akt and PKC activation and inhibit ERK signaling
CC       (PubMed:20819118). Akt regulates the balance between cell survival and
CC       apoptosis through a cascade that primarily alters the function of
CC       transcription factors that regulate pro- and antiapoptotic genes.
CC       Dephosphorylation of 'Ser-473' of Akt triggers apoptosis and
CC       suppression of tumor growth. Dephosphorylation of PRKCA and PRKCB leads
CC       to their destabilization and degradation. Dephosphorylates STK4 on
CC       'Thr-387' leading to STK4 activation and apoptosis (By similarity).
CC       Dephosphorylates RPS6KB1 and is involved in regulation of cap-dependent
CC       translation (By similarity). Inhibits cancer cell proliferation and may
CC       act as a tumor suppressor (By similarity). Dephosphorylates RAF1
CC       inhibiting its kinase activity (By similarity). May act as a negative
CC       regulator of K-Ras signaling in membrane rafts (PubMed:12594205).
CC       Involved in the hippocampus-dependent long-term memory formation (By
CC       similarity). Involved in circadian control by regulating the
CC       consolidation of circadian periodicity after resetting (By similarity).
CC       Involved in development and function of regulatory T-cells (By
CC       similarity). {ECO:0000250|UniProtKB:O60346,
CC       ECO:0000250|UniProtKB:Q8CHE4, ECO:0000269|PubMed:12594205,
CC       ECO:0000269|PubMed:20819118}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Insensitive to okadaic acid. Deubiquitination by
CC       WDR48-USP12 complex positively regulates PHLPP1 stability.
CC       {ECO:0000250|UniProtKB:O60346}.
CC   -!- SUBUNIT: Interacts with the nucleotide free form of K-Ras (KRAS) via
CC       its LRR repeats (PubMed:12594205). Interacts with AKT2, AKT3 and PRKCB
CC       isoform beta-II. Interacts with WDR48 and USP12 (By similarity).
CC       {ECO:0000250|UniProtKB:O60346, ECO:0000269|PubMed:12594205}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12594205}. Membrane
CC       {ECO:0000269|PubMed:12594205}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:12594205}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:20819118}. Cell membrane
CC       {ECO:0000269|PubMed:20819118}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:20819118}. Nucleus membrane
CC       {ECO:0000269|PubMed:20819118}. Cytoplasm {ECO:0000269|PubMed:20819118}.
CC       Cell membrane {ECO:0000269|PubMed:20819118}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=beta;
CC         IsoId=Q9WTR8-1; Sequence=Displayed;
CC       Name=2; Synonyms=alpha;
CC         IsoId=Q9WTR8-2; Sequence=VSP_057811;
CC   -!- TISSUE SPECIFICITY: Mainly present in brain (at protein level)
CC       (PubMed:10570941). Isoform 2 is more abundant in adult brain neurons
CC       than isoform 1 in (PubMed:20819118). Isoforms 1 and 2 are expressed in
CC       the retina but not found in rod outer segments (PubMed:20089132).
CC       {ECO:0000269|PubMed:10570941, ECO:0000269|PubMed:20089132,
CC       ECO:0000269|PubMed:20819118}.
CC   -!- DEVELOPMENTAL STAGE: In the suprachiasmatic nucleus, it increases
CC       during subjective night with a peak at midnight under constant dark
CC       conditions. Expressed at a constant level in neurons throughout the
CC       brain (at protein level) (PubMed:10570941). Isoform 2 expression
CC       increases over development and maturation in the hippocampus. Isoform 1
CC       expression is low in embryonic stages, increases during postnatal
CC       development and is falling back to low embryonic levels in adulthood
CC       (PubMed:20819118). {ECO:0000269|PubMed:10570941,
CC       ECO:0000269|PubMed:20819118}.
CC   -!- INDUCTION: Inhibited by insulin in a PI3K-dependent manner.
CC       {ECO:0000269|PubMed:20089132}.
CC   -!- DOMAIN: The PH domain is required for interaction with PRKCB and its
CC       dephosphorylation. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB023624; BAA77767.1; -; mRNA.
DR   RefSeq; NP_067689.1; NM_021657.1.
DR   AlphaFoldDB; Q9WTR8; -.
DR   SMR; Q9WTR8; -.
DR   BioGRID; 248740; 1.
DR   IntAct; Q9WTR8; 1.
DR   STRING; 10116.ENSRNOP00000003840; -.
DR   PhosphoSitePlus; Q9WTR8; -.
DR   PaxDb; 10116-ENSRNOP00000003840; -.
DR   GeneID; 59265; -.
DR   KEGG; rno:59265; -.
DR   UCSC; RGD:621308; rat. [Q9WTR8-1]
DR   AGR; RGD:621308; -.
DR   CTD; 23239; -.
DR   RGD; 621308; Phlpp1.
DR   eggNOG; KOG0618; Eukaryota.
DR   InParanoid; Q9WTR8; -.
DR   OrthoDB; 3677323at2759; -.
DR   PhylomeDB; Q9WTR8; -.
DR   Reactome; R-RNO-199418; Negative regulation of the PI3K/AKT network.
DR   PRO; PR:Q9WTR8; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0009649; P:entrainment of circadian clock; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:0090038; P:negative regulation of protein kinase C signaling; IMP:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:0090037; P:positive regulation of protein kinase C signaling; IMP:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0046328; P:regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:1900744; P:regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0002667; P:regulation of T cell anergy; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd13322; PH_PHLPP-like; 1.
DR   CDD; cd00143; PP2Cc; 1.
DR   CDD; cd17240; RA_PHLPP1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.60.40.10; PPM-type phosphatase domain; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 3.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR050216; LRR_domain-containing.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR036457; PPM-type-like_dom_sf.
DR   InterPro; IPR001932; PPM-type_phosphatase-like_dom.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   PANTHER; PTHR48051; -; 1.
DR   PANTHER; PTHR48051:SF37; PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE 2; 1.
DR   Pfam; PF00560; LRR_1; 1.
DR   Pfam; PF13516; LRR_6; 1.
DR   Pfam; PF13855; LRR_8; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00481; PP2C; 1.
DR   Pfam; PF23010; RA_3; 2.
DR   SMART; SM00364; LRR_BAC; 10.
DR   SMART; SM00369; LRR_TYP; 9.
DR   SMART; SM00332; PP2Cc; 1.
DR   SUPFAM; SSF52058; L domain-like; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF81606; PP2C-like; 1.
DR   PROSITE; PS51450; LRR; 17.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS51746; PPM_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; Cell membrane; Cytoplasm;
KW   Hydrolase; Leucine-rich repeat; Manganese; Membrane; Metal-binding;
KW   Nucleus; Phosphoprotein; Protein phosphatase; Reference proteome; Repeat;
KW   Tumor suppressor.
FT   CHAIN           1..1696
FT                   /note="PH domain leucine-rich repeat protein phosphatase 1"
FT                   /id="PRO_0000057783"
FT   DOMAIN          499..599
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REPEAT          601..622
FT                   /note="LRR 1"
FT   REPEAT          624..645
FT                   /note="LRR 2"
FT   REPEAT          655..676
FT                   /note="LRR 3"
FT   REPEAT          678..699
FT                   /note="LRR 4"
FT   REPEAT          701..722
FT                   /note="LRR 5"
FT   REPEAT          724..746
FT                   /note="LRR 6"
FT   REPEAT          836..857
FT                   /note="LRR 7"
FT   REPEAT          858..879
FT                   /note="LRR 8"
FT   REPEAT          881..902
FT                   /note="LRR 9"
FT   REPEAT          904..925
FT                   /note="LRR 10"
FT   REPEAT          926..947
FT                   /note="LRR 11"
FT   REPEAT          950..971
FT                   /note="LRR 12"
FT   REPEAT          976..996
FT                   /note="LRR 13"
FT   REPEAT          1000..1021
FT                   /note="LRR 14"
FT   REPEAT          1024..1045
FT                   /note="LRR 15"
FT   REPEAT          1047..1068
FT                   /note="LRR 16"
FT   REPEAT          1069..1090
FT                   /note="LRR 17"
FT   REPEAT          1092..1113
FT                   /note="LRR 18"
FT   DOMAIN          1138..1385
FT                   /note="PPM-type phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01082"
FT   REGION          1..97
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          222..398
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1422..1473
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1610..1696
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1694..1696
FT                   /note="PDZ-binding"
FT   COMPBIAS        309..348
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        363..379
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1427..1473
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1631..1645
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1173
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P35813"
FT   BINDING         1173
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P35813"
FT   BINDING         1174
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P35813"
FT   BINDING         1337
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P35813"
FT   BINDING         1376
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P35813"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:O60346"
FT   MOD_RES         378
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60346"
FT   VAR_SEQ         1..475
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_057811"
SQ   SEQUENCE   1696 AA;  183364 MW;  B4C3CC777B8BB6A9 CRC64;
     MEPAAAAPAQ RLADPTGEDR APAAAAAAEG GRSPDSVLSA AAPSGGNGGA AREEAPCEAP
     PGPLPGRAGG TGRRRRRGVP QPAAGGAAPV TAAGGGANSL LLRRGRLKRN LSAAASSSSS
     PSSASSAAGG LPASCSASAS LCTRSLDRKT LLQKHRQLLQ LQPSDRDWVR HQLQRGCVHV
     FDRHMASSYL RPVLCTLDTT AAEVAARLLQ LGHKGGGVVK VLGHGPPPAA APAASDQTPA
     TELGRDVEPP PSSSTVGAVR GPARAPPADL PLPGGAWTRC APRVNPAPSD SSPGELFAGG
     PCSPSRAPRP ASDTESFSLS PSAESVSDRL DPYSSGGGSS SSSEELEADP ATVLTGPSGP
     PHHPVRSSQP RPPSPKTSAL LQPKAPTGVD GTGLVVGEGP GDDKAVAAAA PGVPLWTPGR
     IRETVQKTSS PPSLYVQLHG ETTRRLEADE KPLQIQNDYL FQLGFGELWR VQEEGMDSEI
     GCLIRFYAGK PHSTGSSERI QLSGMYNVRK GKMQLPVNRW TRRQVILCGT CLIVSSVKDS
     SSGKMHVLPL IGGKVEEVKK HQHCLAFSSS GPQSQTYYIC FDTFTEYLRW LRQVSKVASQ
     RISSVDLSCC SLEHLPANLF YSQDLTHLNL KQNFLRQNPS LPAARGLGEL QRFTKLKSLN
     LSNNHLGAFP SAVCSIPTLA ELNVSCNALQ EVPAAVGAMQ NLQTFLLDGN FLQSLPAELE
     NMHQLSYLGL SFNEFTDIPE VLEKLTAVDK LCMAGNCMET LRLQALRRMP HIKHVDLRLN
     ILRKLITDEV DFLQHVTQLD LRDNKLGDLD AMIFNNIEVL HCERNQLVTL NICGYFLKAL
     YASSNELVQL DVYPVPNYLS YMDVSRNCLE SVPEWVCESR KLEVLDIGHN QICELPARLF
     CNSSLRKLLA GHNRLARLPE RLERTSVEVL DVQHNQIIEL PPNLLMKADS LRFLNASANK
     LETLPPATLS EETSSILQEL YLTNNSLTDK CVPLLTGHPR LKILHMAYNR LQSFPASKMA
     KLEELEEIDI SGNKLKAIPT TIMNCRRMHT VIAHSNCIEV FPEVMQLPEV KCVDLSCNEL
     SEITLPENLP PKLQELDLTG NPRLALDHKS LELLNNIRCF KIDQPSAGDA SGAPAVWSHG
     YTEASGVKNK LCVAALSVNN FRDNREALYG VFDGDRNVEV PYLLQCTMSD ILAEELQKTK
     NEEEYMVNTF IVMQRKLGTA GQKLGGAAVL CHIRHDPVDL GGSFTLTSAN VGKCQTVLCR
     NGKPLSLSRS YTMSCEEERK RIKQHKAIIT EDGKVNGVTE STRILGYTFL HPSVVPRPHV
     QSVLLTPQDE FFILGSKGLW DSLSIEEAVE AVRNVPDALA AAKKLCTLAQ SYGCHDSISA
     VVVQLSVTED SFCCCELSVG GSMPPPSPGI FPPSVSMVIK DRPSDGLGVP SSSSGMASEI
     SSELSTSEMS SEVGSTASDE PPSGALSESS PAYPSEQRCM LHPVCLSNSF QRQLSSATFS
     SAFSDNGLDS DDEEPIEGVF SNGSRVEVEV DIHCSRAKEK ERQQHLLQVP AEASDEGIVI
     SANEDESGLS KKTDISAVGT IGRRRANGSV PPQERSHNVI EVATDAPLRK PGGYFAAPAQ
     PDPDDQFIIP PELEEEVKEI MKHHQEQQQQ QQQQQQQQQQ QPPPPPQPPQ AQAQAQAQAQ
     RPFQMDHLPD CYDTPL
//
